Cargando…
Oroxylin A, but Not Vasopressin, Ameliorates Cardiac Dysfunction of Endotoxemic Rats
The mortality in septic patients with myocardial dysfunction is higher than those without it. Beneficial effects of flavonoid oroxylin A (Oro-A) on endotoxemic hearts were evaluated and compared with that of arginine vasopressin (AVP) which is used to reverse hypotension in septic patients. Endotoxe...
Autores principales: | Liu, Chin-Hung, Chen, Mei-Fang, Tseng, Tzu-Ling, Chen, Lih-Geeng, Kuo, Jon-Son, Lee, Tony Jer-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489109/ https://www.ncbi.nlm.nih.gov/pubmed/23193421 http://dx.doi.org/10.1155/2012/408187 |
Ejemplares similares
-
Klotho suppresses the inflammatory responses and ameliorates cardiac dysfunction in aging endotoxemic mice
por: Hui, Haipeng, et al.
Publicado: (2017) -
Oroxylin-A Rescues LPS-Induced Acute Lung Injury via Regulation of NF-κB Signaling Pathway in Rodents
por: Tseng, Tzu-Ling, et al.
Publicado: (2012) -
Neonatal immune challenge impairs endotoxemic shock-induced hypotension: potential role for vasopressin
por: Carnio, EC, et al.
Publicado: (2010) -
Long-Term Exposure to Oroxylin A Inhibits Metastasis by Suppressing CCL2 in Oral Squamous Cell Carcinoma Cells
por: Ku, Wei-Ting, et al.
Publicado: (2019) -
17-DMAG, an HSP90 Inhibitor, Ameliorates Multiple Organ Dysfunction Syndrome via Induction of HSP70 in Endotoxemic Rats
por: Wang, Yi-Li, et al.
Publicado: (2016)